0001562180-23-006338.txt : 20230815
0001562180-23-006338.hdr.sgml : 20230815
20230815145041
ACCESSION NUMBER: 0001562180-23-006338
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20230811
FILED AS OF DATE: 20230815
DATE AS OF CHANGE: 20230815
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lai Quintin J
CENTRAL INDEX KEY: 0001744326
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-08036
FILM NUMBER: 231174519
MAIL ADDRESS:
STREET 1: 530 HERMAN 0. WEST DRIVE
CITY: EXTON
STATE: PA
ZIP: 19341
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: WEST PHARMACEUTICAL SERVICES INC
CENTRAL INDEX KEY: 0000105770
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 231210010
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 530 HERMAN O. WEST DRIVE
CITY: EXTON
STATE: PA
ZIP: 19341
BUSINESS PHONE: 6105942900
MAIL ADDRESS:
STREET 1: 530 HERMAN O. WEST DRIVE
CITY: EXTON
STATE: PA
ZIP: 19341
FORMER COMPANY:
FORMER CONFORMED NAME: WEST CO INC
DATE OF NAME CHANGE: 19990405
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0508
4
2023-08-11
false
0000105770
WEST PHARMACEUTICAL SERVICES INC
WST
0001744326
Lai Quintin J
530 HERMAN O. WEST DRIVE
EXTON
PA
19341
false
true
false
false
VP Strat & Investor Relations
false
Common Stock
2023-08-11
4
M
false
8772.00
89.64
A
27078.93
D
Common Stock
2023-08-11
4
M
false
7140.00
102.51
A
34218.93
D
Common Stock
2023-08-11
4
M
false
3348.00
173.22
A
37566.93
D
Common Stock
2023-08-11
4
M
false
1388.00
274.29
A
38954.93
D
Common Stock
2023-08-11
4
M
false
453.00
369.13
A
39407.93
D
Common Stock
2023-08-11
4
S
false
10725.00
394.6225
D
28682.93
D
Common Stock
2023-08-11
4
S
false
8635.00
395.5426
D
20047.93
D
Common Stock
2023-08-11
4
S
false
1741.00
396.123
D
18306.93
D
Stock Option (Right to Buy)
89.64
2023-08-11
4
M
false
8772.00
0.00
D
2019-02-20
2028-02-20
Common Stock
8772.00
0.00
D
Stock Options (Right to buy)
102.51
2023-08-11
4
M
false
7140.00
0.00
D
2020-02-19
2029-02-19
Common Stock
7140.00
0.00
D
Stock Options (Right to Buy)
173.22
2023-08-11
4
M
false
3348.00
0.00
D
2021-02-18
2030-02-18
Common Stock
3348.00
1116.00
D
Stock Options (Right to buy)
274.29
2023-08-11
4
M
false
1388.00
0.00
D
2021-02-23
2031-02-23
Common Stock
1388.00
1388.00
D
Stock Options (Right to buy)
369.13
2023-08-11
4
M
false
453.00
0.00
D
2023-02-22
2032-02-22
Common Stock
453.00
1359.00
D
The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $393.97 to $394.96, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $394.97 to $395.93, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $395.97 to $396.45, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
This option is fully vested.
This award vests in four equal annual installments beginning on February 18, 2021.
This award vests in 4 equal annual installments beginning on 2/23/2022.
This award vests in four equal annual installments beginning on February 22, 2023.
Ryan Metz as Agent for Quintin J. Lai
2023-08-14
EX-24
2
poalai.txt
POALAI
LIMITED POWER OF ATTORNEY FOR
WEST PHARMACEUTICAL SERVICES, INC.
SECTION 16(a) FILINGS
Know all by these presents that the undersigned hereby constitutes and
appoints each of Luis Cantarero, Jeffrey Tse, Ryan Metz and
Joanne Boyle, signing singly, the undersigneds true and lawful
attorney-in-fact to:
(1) Execute for and on behalf of the undersigned, in the undersigneds
capacity as an officer, director and/or shareholder of West Pharmaceutical
Services, Inc. (the Company), Forms 3, 4, and 5 and amendments thereto
in accordance with Section 16(a) of the Securities Exchange Act of 1934 and
the rules thereunder;
(2) Do and perform any and all acts for and on behalf of the undersigned
which may be necessary or desirable to complete and execute any such Form
3, 4, or 5 or amendment thereto and timely file such form with the United
States Securities and Exchange Commission (the SEC) and any stock exchange
or similar authority; and
(3) Take any other action of any type whatsoever, which, in the opinion of
such attorney-in-fact, may be necessary or desirable in connection with the
foregoing authority, it being understood that the documents executed by
such attorney-in-fact on behalf of the undersigned pursuant to this Power of
Attorney shall be in such form and shall contain such terms and conditions
as such attorney-in-fact may approve.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and
powers herein granted, as fully to all intents and purposes as the undersigned
might or could do if personally present, with full power of substitution or
revocation, hereby ratifying and confirming all that such attorney-in-fact,
or such attorney-in-facts substitute or substitutes, shall lawfully do or
cause to be done by virtue of this Power of Attorney and the rights and
powers herein granted.
The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in
such capacity at the request of the undersigned, are not assuming, nor is the
Company assuming, any of the undersigneds responsibilities to comply with
Section 16 of the Securities Exchange Act of 1934.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to
the undersigneds holdings of and transaction in securities of the Company,
unless earlier revoked by the undersigned in a signed writing delivered to
the foregoing attorneys-in-fact. This Power of Attorney may be filed with the
SEC as a confirming statement of the authority granted herein.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 26th day of Feb 2018.
SIGNATURE
/s/ Quintin J. Lai